Literature DB >> 8011562

ACE inhibitors versus diuretics: when to choose which drug?

N Sharpe1.   

Abstract

ACE inhibitors and diuretics should be used in combination in the majority of patients with clinical congestive heart failure. The broad spectrum of heart failure should include the phase of significant left ventricular dysfunction without overt clinical heart failure for which ACE inhibitor treatment alone may be beneficial in selected cases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8011562     DOI: 10.1007/bf00877718

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  11 in total

Review 1.  Activation of neurohumoral systems following acute myocardial infarction.

Authors:  J L Rouleau; L A Moyé; J de Champlain; M Klein; D Bichet; M Packer; G Dagenais; B Sussex; J M Arnold; F Sestier
Journal:  Am J Cardiol       Date:  1991-11-18       Impact factor: 2.778

2.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

3.  Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction.

Authors:  N Sharpe; J Murphy; H Smith; S Hannan
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

4.  Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition.

Authors:  N Sharpe; H Smith; J Murphy; S Greaves; H Hart; G Gamble
Journal:  Lancet       Date:  1991-04-13       Impact factor: 79.321

5.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

6.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.

Authors:  H D White; R M Norris; M A Brown; P W Brandt; R M Whitlock; C J Wild
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

7.  Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure.

Authors:  A Richardson; J Bayliss; A J Scriven; J Parameshwar; P A Poole-Wilson; G C Sutton
Journal:  Lancet       Date:  1987-09-26       Impact factor: 79.321

8.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

9.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

Authors:  S Yusuf; B Pitt; C E Davis; W B Hood; J N Cohn
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

Review 10.  Angiotensin-converting enzyme inhibitor and spironolactone combination therapy. New objectives in congestive heart failure treatment.

Authors:  F Zannad
Journal:  Am J Cardiol       Date:  1993-01-21       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.